When to get a sore joint checked

What to notice before you call

Notice where soreness begins and whether it moves beyond one joint. Write down swelling, catching, weakness, lost sleep, and stiffness after rest. Don't test a weak joint by pushing through stairs or lifting alone.

Several swollen joints may mean the immune system is attacking the joint lining. That kind of arthritis needs a rheumatologist, a doctor who treats immune-driven joint illness. Tell that doctor about a rash, eye trouble, or long morning stiffness too.

What to bring to the visit

Bring a medicine list, old joint reports, X-rays, and blood test results. The clinician may check movement, strength, swelling, and tender areas. A new X-ray can look for bone damage, while blood tests can check for immune-driven illness.

A QC Kinetix consultation may cover regenerative treatments, non-surgical procedures using material from your body. Its medical providers, the clinicians who examine you, may discuss PRP or advise care elsewhere. You could leave with home instructions, a treatment discussion, a rheumatologist referral, or a request for another test.

When to leave with a clear plan

Before leaving, repeat the instructions in your own words. Ask which movement is safe, which warning sign needs help, and when relief might begin. Keep asking until you know what to do at home.

Care might include exercise, therapy, medicine, a procedure, or another doctor. The cause of the soreness and your overall health guide that decision. No treatment is right for every sore joint.

Sources

1. The 2010 ACR/EULAR classification criteria define 'definite rheumatoid arthritis' by confirmed synovitis in at least one joint, absence of a better alternative diagnosis, and a total score of 6 or more out of 10 across four domains: number and site of involved joints (0-5), serology (0-3), acute-phase response (0-1) and symptom duration (0-1). This is the formal boundary between inflammatory arthritis and degenerative joint disease.

   Aletaha D, et al. — 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.. Arthritis Rheum, 2010. DOI: 10.1002/art.27584.

2. The 2025 EULAR update recommends methotrexate, ideally combined with short-term glucocorticoids, as initial therapy for rheumatoid arthritis, within a treat-to-target strategy across conventional synthetic, biological and targeted synthetic DMARDs - a disease-modifying drug pathway that has no counterpart in osteoarthritis and which belongs to rheumatology.

   Smolen JS, et al. — EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update.. Ann Rheum Dis, 2026. DOI: 10.1016/j.ard.2026.01.023.

3. The 2019 ACR/Arthritis Foundation guideline makes STRONG recommendations for exercise, weight loss in people with overweight or obesity, self-efficacy and self-management programmes, tai chi, cane use, hand orthoses for first-CMC joint OA, tibiofemoral bracing, topical NSAIDs for the knee, oral NSAIDs and intra-articular glucocorticoid injections for the knee; acupuncture, thermal modalities, radiofrequency ablation, acetaminophen, duloxetine and tramadol are only conditional.

   Kolasinski SL, et al. — 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee.. Arthritis Rheumatol, 2020. DOI: 10.1002/art.41142.

4. In the only randomized trial of total knee replacement (100 patients with moderate-to-severe knee OA), the surgery group improved more on the KOOS4 score at 12 months than the non-surgical group (32.5 vs 16.0; adjusted mean difference 15.8, 95% CI 10.0 to 21.5) - but had four times the serious adverse events (24 vs 6, P=0.005), and 26% of the non-surgical group chose surgery within the year while 74% did not.

   Skou ST, et al. — A Randomized, Controlled Trial of Total Knee Replacement.. N Engl J Med, 2015. DOI: 10.1056/NEJMoa1505467.